Patients avoid genetic tests, fearing insurer backlash

As FierceHealthcare readers know, researchers soon hope to tailor treatments to patients based on their genetic profile. The thing is, it will be hard to do that if patients are reluctant to take genetic tests. Unfortunately, though, it appears that this is just what many are doing, afraid that such results will be used against them by insurers, according to a recent report in The New York Times. And while a bill outlawing genetic discrimination was filed in the U.S. House of Representatives last year, it hasn't reached the Senate yet.

Meanwhile, patient fears may be well-founded. One study by the Georgetown University Health Policy Institute found that in 7 out of 92 hypothetical underwriting decisions, insurers said they would deny coverage, charge higher premiums or exclude some conditions from coverage based on genetic test results.

To learn more about this issue:
- read this FierceBioResearcher piece
- read the piece in The New York Times

Related Articles:
CA bill requires permission for cancellations. Article
Blue Cross of CA halts patient info requests. Article
Blue Cross asks MDs for info to cancel policies. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.